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Cardiac Pacing in Hong Kong: Second Report of the Hong Kong
Pacing Registry
THE HONG KONG PACING REGISTRY INVESTIGATORS
From the Hong Kong Pacing Registry, Hong Kong College of Cardiology, Room 1220, Bank of America Tower,
12 Harcourt Road, Central, Hong Kong
THE HONG KONG PACING REGISTRY INVESTIGATORS: Cardiac Pacing in Hong Kong: Second Report
of the Hong Kong Pacing Registry. The first permanent pacemaker was implanted in Hong Kong in early seventies.
Since then, the use of permanent pacing has steadily increased. The manufactures' sales figures were the only source
of reference. In 1990, a Hong Kong Pacing Registry was set up, with the aim to establish a reliable source of
pacemaker use in Hong Kong. Data were entered into a registry form during every permanent pacemaker implantation.
The areas focused were: patient demographics (sex, age, symptomatology, associated medical illnesses and rhythm
problems), pacemaker system characteristics (polarity, programmability and pacing mode) and implant procedure
(site and route of entry and implant parameters). A total of 7767 forms were returned for years 1991-2002. There
was a steady increase in the number of pacemaker implanted, with 77 and 125 per million population received their
first implant in the year 1991 and 2002 respectively. Response rates to most individual items of the returned forms
were over 90% (range 2.2-100%). The male: female ratio was 1:1.4. Dizziness (36.1%) and syncope (23.8%) were
the main symptoms at presentation, and sick sinus syndrome (31.6%) and high grade heart block (37.3%) were the
main rhythm indications for pacing. Significant proportion of the patients had associated medical diseases such as
hypertension (24.4%) and ischaemic heart disease (13.3%). The relative frequencies of pacing modes used were:
DDDR (34.2%), VVI (29.5%), VVIR (20.8%), DDD (10%), VDD(R) (2.5%) and AAIR (0.7%). The percentage of
dual chamber pacemakers had increased from 27% in 1991 to 62% in 2002. Most pacemakers were implanted on the
left side, with subclavian puncture technique being the usual procedure. In conclusion, these data from the Hong
Kong Pacing Registry give a good account of the patient demographics and pacing practice in Hong Kong for years
1991-2002, which would be useful as a future source of reference. The registry has been updated to include data on
new indications for pacing and implantable cardioverter defibilators. (J HK Coll Cardiol 2003;11:63-70)
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Introduction
The practice of cardiac pacing differs enormously
between countries.1 The difference is not only reflected
in the implant rate (ranging from 158 per million
population in Japan to 13 per million population in
Malaysia), but also in the pacemaker prescription.
Accurate data in some Asian Pacific countries are not
readily available, as a country-wide pacing registry is
not implemented in most countries in this part of the
world. The implant rate in this region can only be
indirectly assessed from manufactures' sales records.
Permanent pacing was first used in Hong Kong
in the early seventies. The number of units used has
increased over the years, reaching a total implant rate
of about 91 per million population in 1991 (from
manufacturer sales data). There is a need to gather some
basic information on the quality and quantity of pacing
practice in Hong Kong. This information could be useful
for trend analysis, as well as providing a useful reference
source for monitoring device safety and for patient
tracking. A Hong Kong Pacing Registry was established
in 1990 with this background. Data from the PreRegistry era (1975-1990) was reported in a previous

article.2 This article summarises the information on the
practice of cardiac pacing collected from the Registry
since its inception to the year 2002.

Methods
Pacing Registry
A registry form was designed by a working group
on pacing registry, who are members of the Hong Kong
Cardiological Society (now the Hong Kong College of
Cardiology). The registry is now under the Working
Group of Cardiac Pacing and Arrhythmias of the
College. The questionnaire consists of a total of 12 entry
items, which can be grouped into 3 basic categories
(Table 1). These are: (1) patient demographics, (2)
pacemaker system characteristics and, (3) implant
procedure.
A registry form was filled in by the pacemaker
representative at the time of implant. In the local setting
a pacemaker representative is always present at
implantation. Clinical data were supplied by the
implanting physician/surgeon. Neither the name of the
patients and the implanters, nor the institutions where

Table 1. Entry items in the Hong Kong Pacing Registry
Categories

Entries

Patient demographics

Sex, age, symptoms, medical illnesses, rhythm disturbances

Pacemaker system characteristics

New implant or replacement, lead manufacturer, polarity, pacing mode
and manufacturer

Pacing procedure

Date of implant, implant parameters and venous access
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the implantation was performed, were required. The
completion and return of the registry forms were
voluntary.
Data from the received registry forms were
entered into a data base system. Statistical analysis were
made on the forms received from 1991 to 2002.

Results
Registry Data
To assess the completeness of the voluntary
report, the total number of pacemakers sold locally from
all the pacemaker companies in Hong Kong were

obtained. Only figures for years 1991 and for years
2000-2003 were available. The discrepancy between the
number of pacemakers sold locally and number of forms
returned to the Registry indicates that not all forms are
returned (Table 2). The average returned rate for these
years were 83.9%.
With a population of 5.5 million in 1991, the
implant rate (from the actual number of pacemakers
sold) was about 91 per million population, and rising to
149 per million population in 2002 when the population
was about 6.8 millions. The total number of forms
returned for 1991-2002 was 7767. There was a steady
increase from 427 in year 1991 to 872 in year 2002
(Figure 1).

Table 2. No. of forms returned against No. of pacemakers sold
Year

1991

2000

2001

2002

No. of implants (pacemakers sold locally)
No. of forms returned
% of returned

530
427
80.6%

783
732
93.5%

1096
824
75.2%

1012
872
86.2%

Figure 1. Number of registry forms returned.
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Patient Demographics
Response rates to individual entries are
summarized in Table 3, ranging from 75.2% to 93.5%.
The male to female ratio was 1:1.4.
Dizziness (36.1%) and syncope (23.8%) were the
main presenting symptoms, and this trend was

maintained throughout the study period (Figure 2). The
commonest associated medical conditions were
hypertension (24.4%) and ischaemic heart disease
(13.3%). 19.2% of patients did not have any associated
medical illness (Figure 3).
High grade atrioventricular block (37.3%) was

Table 3. Patient demographics
Entries
Patient demographics
Sex
Symptoms
Medical illness
Indication
Pacemaker system
Characteristics
All implants
Lead manufacturer
Pacing mode
Pacemaker manufacturer
Implant procedure
Date
Implant parameters
Venous access

Number of forms completed

Completion rate

7744
7055
6111
6008

99.8%
90.1%
78.7%
77.4%

7660
7517
7681
7055

98.6%
96.8%
98.9%
90.8%

7767
7631
7418

100%
98.2%
95.5%

Figure 2. Symptoms at presentation of patients.
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the commonest indication for permanent pacemaker
implantation, followed by sinoatrial disease (31.6%).
Similar trend was observed throughout. Amongst
patients with sinoatrial disease, sinus bradycardia (10%)

and bradycardia-tachycardia syndrome (9.7%) were the
main sub-categories. Slow atrial fibrillation/flutter was
responsible for 12% of the implants. Intraventricular
block was an indication in 1.2% (Figure 4).

Figure 3. Incidence of associated illness.

Figure 4. Indications for permanent pacing.
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Pacemaker System Characteristics
There were 82.5% primary implantations.
Between 1991-2002, the main pacing mode used was
DDDR (34.2%), followed by VVI pacing (29.5%). Dual
chamber modes were used in 44.2%, of which the
majority was DDDR pacemakers (Figure 5). A rate
adaptive single chamber mode (VVIR, 20.8%; AAIR,

0.7%) was the third commonest pacing mode used.
Single lead VDD(R) pacing was first introduced in Hong
Kong in 1991,3 and was utilized in 2.5% cases. There
was a steady increase in the use of dual chamber units
over the period, compared with 62% dual chamber
pacemakers implanted in the year 2002, with only 27%
in 1991 (Figure 6).

Figure 5. Pacing modes used.

Figure 6. Use of Dual Chamber Pacemakers in Hong Kong.
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Pacing Procedure
Most pacing systems were implanted on the left
side (right : left = 1:4.4). The subclavian route was used
in the majority of cases especially for atrial lead
placement (ratio of cephalic: subclavian route being
1:3.9 for atrial and 1:2.0 for ventricular leads,
respectively). The external jugular cut down route and
epicardial placement were used in about 1.35% and
0.8% of cases respectively.

Pacemaker Replacement
There were 1120 first replacement units during
these years, and 122 cases of second replacement.

the higher prevalence of female requiring permanent
pacing, and the near equal ratio of patients with
advanced atrioventricular block and sinoatrial disease
as indications for permanent pacing. There was little
change in this trend throughout these years.
The utility of dual chamber modes also varied.
In the States, 62.4% were dual chamber in 1997.8 In
Europe, it can vary from 17.3% in Croatia to 68.2% in
Belgium.7 In Asia-Pacific region, the dual chamber
implant rate in many countries tend to be low. The Hong
Kong data on use of dual chamber at 62% puts in
amongst that of the developed countries.

Future Role of Pacing Registry

Discussion
The use of permanent pacing on a worldwide
basis is significantly affected by the prevalence of
symptomatic bradyarrhythmias, socioeconomic state,
health care policy and, to a certain extent, physicians'
awareness and understanding of permanent pacing.1,4
As a result, there are significant differences worldwide
in the use of permanent pacing, as documented in two
surveys in 19865 and in 19896 respectively.
An implant rate of 149 per million population (or
125 new implants per million) is amongst the highest in
Asia; and is comparable to the 158 new implants per
million in Japan in 2001. However, this rate is low
compared to the developed countries in which data were
available, which was 378 and 571 per million in the
year 1987-1998 in Europe and the States respectively.7-8
Perhaps one of the main reasons is that ischaemic heart
disease, which is one of the main causes of symptomatic
bradyarrhythmias, is high in these countries. Indeed,
ischaemic heart disease was an associated condition in
about 13.3% of patients with permanent pacemakers in
Hong Kong, whereas a figure of 35-78% was quoted in
one study from Sweden. 9 On the other hand,
hypertension was present in a much more comparable
percentage (24.4% in Hong Kong versus 24% in
Sweden).
One salient difference between patient
demographics in Hong Kong and the Western world is
69

The present registry data, although providing
significant information, are limited in several ways. The
completion of the Registry form was voluntary, and data
collected were somewhat incomplete. Corrections of
some minor design defects in the Registry form has been
implemented in 2003. Barriers to form completion has
been identified and dealt with. The registry has now
been updated to include new indication of pacing such
as for heart failure, and to include a registry for
implantable cardioverter defibrillators.
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